Ann: Quarterly Update and Appendix 4C, page-29

If I understand correctly, the problem with MSB is that their management failed to comply to the FDA wishes. FDA said you need to do this last time round. But the management thinks they know better and do it their way instead. And sure enough, FDA is now saying again, 'YOU NEED TO DO THIS!'. Hence their shareholders get bitterly disappointed.

Over here, PD and team has been in full collaboration with the FDA. This is why it is taking so long and is a slow process. At each juncture, PCK would be in touch with the FDA to ensure it is doing what the FDA required and adjust if required. And so far, it is progressing nicely, as is prescribed by the FDA. The FDA will get what the FDA wants. Anything else, and you are running the risk of them saying NO outright. All these collaboration coupled with real life application out there in reputable countries like Australia, England, NZ, Singapore, etc will put weight in the FDA decision making here. Nothing is a guarantee but this is as good as a sure thing already.

You are spot on there. Just the aged care sector will ensure PCK will reach that revenue neutral status and more. Everything else like the children, hospital, pharmacy, homecare, etc sector, are all going straight into the bottom line. Just a matter of time when anyone who holds shares at today's price are going to be free carried when the dividend starts flowing. And that is ignoring what the capital gains would be by then!